Capital Fund Management (CFM)’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-42,056
| Closed | -$1.91M | – | 943 |
|
|
2022
Q4 | $1.91M | Sell |
42,056
-10,094
| -19% | -$457K | 0.01% | 365 |
|
|
2022
Q3 | $3.64M | Buy |
52,150
+8,541
| +20% | +$597K | 0.03% | 242 |
|
|
2022
Q2 | $2.93M | Sell |
43,609
-6,706
| -13% | -$450K | 0.03% | 286 |
|
|
2022
Q1 | $4.14M | Buy |
50,315
+25,253
| +101% | +$2.08M | 0.03% | 235 |
|
|
2021
Q4 | $3.68M | Buy |
25,062
+8,932
| +55% | +$1.31M | 0.03% | 252 |
|
|
2021
Q3 | $2.85M | Buy |
16,130
+1,852
| +13% | +$328K | 0.02% | 254 |
|
|
2021
Q2 | $2.31M | Buy |
+14,278
| New | +$2.31M | 0.02% | 320 |
|
|
2020
Q3 | – | Sell |
-14,241
| Closed | -$1.63M | – | 894 |
|
|
2020
Q2 | $1.63M | Buy |
14,241
+421
| +3% | +$48.1K | 0.03% | 237 |
|
|
2020
Q1 | $1.06M | Sell |
13,820
-8,120
| -37% | -$624K | 0.02% | 395 |
|
|
2019
Q4 | $2.83M | Buy |
21,940
+13,578
| +162% | +$1.75M | 0.02% | 315 |
|
|
2019
Q3 | $651K | Buy |
+8,362
| New | +$651K | 0.01% | 504 |
|